longevity market

The longevity market is a rapidly expanding sector focused on extending human healthspan and lifespan, driven by significant demographic shifts and advancements in biotechnology. Asia, particularly China, is increasingly viewing the "silver economy" not as a burden but as a pillar of economic growth and national security, with a growing elderly population (over 320 million aged 60+ in China) fueling this strategic focus. Biotech firms are actively racing to reverse or slow the aging process, viewing cellular aging as akin to software errors that can be reprogrammed. Companies are leveraging artificial intelligence (AI) to analyze and potentially rewrite genetic code within human cells, aiming to slow or reverse aging. This burgeoning market, estimated to be worth billions, signifies a paradigm shift in how aging is perceived and addressed, moving from passive acceptance to proactive intervention and economic opportunity.